Adverum Biotechnologies, Inc. (ADVM)
4.36
+0.10
(+2.35%)
USD |
NASDAQ |
Dec 08, 16:00
4.50
+0.14
(+3.21%)
Pre-Market: 20:00
Adverum Biotechnologies EPS Diluted (Quarterly): -2.029 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Quantum-Si, Inc. | -0.1708 |
| X4 Pharmaceuticals, Inc. | -0.689 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.65M |
| Total Expenses (Quarterly) | 47.65M |
| Enterprise Value | 159.14M |
| Earnings Yield | -196.7% |
| Normalized Earnings Yield | -196.66 |